Fabtech Technologies is an India-headquartered global turnkey engineering solutions provider for pharma, biotech and healthcare, operating in 62+ countries. It delivers end-to-end services from design to commissioning for greenfield and brownfield projects, focusing on bio clean air, clean water and process systems. With expertise across dosage forms and a strong track record in emerging markets, it offers customized, efficient and sustainable solutions for complex facilities worldwide.
IPO schedule
Issue open date
2025-09-29
Issue close date
2025-10-01
UPI mandate deadline
2025-10-01 (5 PM)
Allotment finalization
2025-10-03
Refund initiation
2025-10-06
Share credit
2025-10-06
Listing date
2025-10-07
Mandate end date
2025-10-16
Lock-in end date for anchor investors (50%)
2025-11-02
Lock-in end date for anchor investors (remaining)
2026-01-01
Financials
Financial Year Ended
March 2023
March 2024
March 2025
Total Assets
213.86
269.24
426.56
Revenue
199.91
230.39
335.94
Profit After Tax
21.73
27.22
46.45
Issue size
Funds Raised in the IPO
Amount
Overall
₹230.25 crores
Fresh Issue
₹230.25 crores
Utilisation of proceeds
Purpose
INR crores (%)
Working capital requirements
127 (55.16%)
Pursuing inorganic growth initiatives through acquisitions
30 (13.03%)
General corporate purposes
73.25 (31.81%)
Strengths
Integrated turnkey engineering solutions with end-to-end services.
Asset-light model with in-house software and tech capabilities.
Diversified order book across geographies, clients, and business verticals.
Proven execution across complex projects and dosage forms.
Experienced leadership team with Fabtech Group backing.
Risks
Low order conversion rate (less than 11% of proposals) may impact growth.
Limited operating history makes future performance harder to gauge.
Order book may not reflect future results; delays or cancellations can hurt business.
Heavy dependence on promoter group entities for equipment procurement.
High reliance on a limited number of projects; cancellations may severely impact revenue.